Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal disorder due to its unresolved
pathogenesis and limited responsiveness to currently available therapies. It is characterized …

Activated fibroblasts are the central effector cells of the progressive fibrotic process in
idiopathic pulmonary fibrosis (IPF). Characterizing the genomic phenotype of isolated …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by
progressive fibrosing interstitial pneumonia. The histological pattern, which displays dense …

One of the more challenging areas of pulmonary medicine remains elucidating the
pathogenesis of idiopathic pulmonary fibrosis (IPF). IPF is a devastating disease process …

Rationale Contribution of central lung tissues to pathogenesis of idiopathic pulmonary
fibrosis (IPF) remains unknown. Objective To ascertain the relationship between cell types of …

Idiopathic pulmonary fibrosis (IPF) is a progressive and terminal lung disease with no known
cure. IPF is a disease of aging, with median age of diagnosis over 65 years. Median survival …

The prevailing hypothesis regarding the pathogenesis of the fibrotic lung disorders supports
a sequence of events initiated by a lung injury, which is followed by an inflammatory …

Idiopathic pulmonary fibrosis (IPF) is a fascinating and poorly understood disease with
devastating consequences to those afflicted that has undergone several revisions in the last …

Idiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease associated with
aging that is characterized by the histopathological pattern of usual interstitial pneumonia …

Idiopathic pulmonary fibrosis (IPF) is a chronic fibrosing lung disease of indeterminate
etiology and limited therapeutic options. The initiation, development, and progression of IPF …